Complementary to our identification of NK cell expression CD226 as a risk factor for type-1 diabetes and multiple sclerosis (Fig. 1), we identify NK cell expression of CD226 as a determinant of both systemic lupus erythematosus and primary biliary cirrhosis. This evidence concerns the gene CD226 and primary biliary cholangitis.